Related references
Note: Only part of the references are listed.Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
Holly C. Groom et al.
VACCINE (2022)
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Mark G. Thompson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
Margaret K. Doll et al.
CLINICAL INFECTIOUS DISEASES (2022)
Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
Jessie R. Chung et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Association between Covid-19 Vaccination and Influenza Vaccination Rates
Richard K. Leuchter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season
Angiezel Merced-Morales et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018
Mark W. Tenforde et al.
CLINICAL INFECTIOUS DISEASES (2021)
Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season
Hector S. Izurieta et al.
CLINICAL INFECTIOUS DISEASES (2021)
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020
Mark W. Tenforde et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
Peter J. Embi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study
Carlos G. Grijalva et al.
CLINICAL INFECTIOUS DISEASES (2021)
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
M. G. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021
Sonja J. Olsen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019
Hector S. Izurieta et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020
Sonja J. Olsen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Intraseason Waning of Influenza Vaccine Effectiveness
G. Thomas Ray et al.
CLINICAL INFECTIOUS DISEASES (2019)
Influenza Vaccine Effectiveness: Defining the H3N2 Problem
Edward A. Belongia et al.
CLINICAL INFECTIOUS DISEASES (2019)
Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness
Alicia P. Budd et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies
Barnaby Young et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
Kate Russell et al.
VACCINE (2018)
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015
Danuta M. Skowronski et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine
Nicholas C. Wu et al.
PLOS PATHOGENS (2017)
Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects
Danuta M. Skowronski et al.
CLINICAL INFECTIOUS DISEASES (2017)
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Edward A. Belongia et al.
LANCET INFECTIOUS DISEASES (2016)
Immunosenescence: emerging challenges for an ageing population
Danielle Aw et al.
IMMUNOLOGY (2007)